M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma
Authors:
Open Access
- 14 January 2023
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-19
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is a deadly gastrointestinal malignancy, and chemotherapy resistance is a key factor leading to its poor prognosis. M2 tumor-associated macrophages (M2-TAMs) may be an important cause of chemoresistance in ESCC, but its exact mechanism is still unclear. Methods: In order to study the role of M2-TAMs in ESCC chemoresistance, CCK-8, clone formation assay, flow cytometric apoptosis assay, qRT-PCR, western blotting, and serum-free sphere formation assays were used. In vivo animal experiments and human ESCC tissues were used to confirm the findings. Results: In vitro and in vivo animal experiments, M2-TAMs reduced the sensitivity of ESCC cells to cisplatin. Mechanistically, M2-TAMs highly secreted TGF-β1 which activated the TGFβR1-smad2/3 pathway to promote and maintain the stemness characteristic of ESCC cells, which could inhibit the sensitivity to cisplatin. Using TGFβ signaling inhibitor SB431542 or knockdown of TGFβR1 could reverse the cisplatin resistance of ESCC cells. In 92 cases of human ESCC tissues, individuals with a high density of M2-TAMs had considerably higher levels of TGF-β1. These patients also had worse prognoses and richer stemness markers. Conclusion: TGF-β1 secreted from M2-TAMs promoted and maintained the stemness characteristic to induce cisplatin resistance in ESCC by activating the TGFβ1-Smad2/3 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81960435, 81760428)
- International Science and technology cooperation promotion project of Shihezi University (GJHZ202001)
- the Non-profit Central Research InstituteFund of Chinese Academy of Medical Sciences (2020-PT330-003)
- Graduate Education Innovation Program of Xinjiang Autonomous Region (XJ2022G112)
This publication has 62 references indexed in Scilit:
- MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathwayMolecular Medicine Reports, 2015
- Esophageal CarcinomaNew England Journal of Medicine, 2014
- A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53mut exhibits ATP-binding cassette transporter upregulation and high glutathione levelsJournal of Cancer Research and Clinical Oncology, 2014
- Overview: Cellular plasticity, cancer stem cells and metastasisCancer Letters, 2013
- The roles of TGFβ in the tumour microenvironmentNature Reviews Cancer, 2013
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Molecular mechanisms of cisplatin resistanceOncogene, 2011
- Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populationsOncogene, 2011
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- TGFβ in CancerCell, 2008